Introducing GPT-Rosalind for life sciences research

OpenAI Blog ·

OpenAI released GPT-Rosalind, a domain-specific frontier reasoning model for life sciences covering drug discovery, genomics, and protein reasoning, now in research preview with Moderna and Amgen as launch partners.

Categories: Model Releases, Products to Try

Excerpt

OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.

Read at source: https://openai.com/index/introducing-gpt-rosalind